Ahead of World AIDS Day, Uganda is recruiting women to participate in a trial of an injectable antiretroviral drug to replace Truvada, a daily pill that has low adherence by users. The trial will assess if the new drug - Cabotegravir - can further reduce the risk of acquiring HIV. Halima Athumani has more from Kampala.
Researchers are rapidly learning how to edit DNA to fight such conditions as Huntington’s, Tay-Sachs and hereditary heart disease, conducting legally permissible experiments in lab animals and petri dishes without taking the ultimate step of actually creating babies
On Dec. 1, we observe the 30th World AIDS Day. There's been a lot of progress over the past 30 years, but people still die from AIDS. And others are newly infected every day. As VOA's Carol Pearson reports, we have the tools to end the epidemic, but it's far from over.